Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-arterial urokinase after successful thrombectomy for anterior circulation acute ischemic stroke
ChiCTR2200066426Phase 4Not yet recruiting
- Sponsor
- Heyuan People's Hospital
- Start
- Dec 2022
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of urokinase in ischemic stroke (2 arms), sponsored by Heyuan People's Hospital. Primary endpoint: 90-day modified Rankin Scale 0-2. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
urokinase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2200066426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066426.